Job Watch

Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)

Funding Opportunity PAR-19-199 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research which can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses. Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation.

Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)

Funding Opportunity PAR-19-198 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research which can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses. Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation.

ASSISTANT RESEARCHER - University of Wisconsin–Madison - Madison, WI

Indeed.com - Bioinformatics - Tue, 2019-02-26 19:57
Applicant must be willing to learn to conduct new molecular sequencing and bioinformatics approaches for analysis of plant pathogens affecting specialty crops....
From University of Wisconsin–Madison - Wed, 27 Feb 2019 00:57:35 GMT - View all Madison, WI jobs
Categories: Job Watch

Bioinformatics Analyst I - Broad Omics Support - Medical College of Wisconsin - Milwaukee, WI

Indeed.com - Bioinformatics - Tue, 2019-02-26 16:07
Development of automated analysis methods to assess model quality and features, as well as the analysis of Molecular Dynamics simulations using statistical...
From Medical College of Wisconsin - Tue, 26 Feb 2019 21:07:30 GMT - View all Milwaukee, WI jobs
Categories: Job Watch

EMBL: EvoCELL Short Early Stage Researcher

New Scientist - Bioinformatics - Tue, 2019-02-26 04:38
Competitive Salary: EMBL: EvoCELL Short Early Stage Researcher Location: Germany (DE)
Categories: Job Watch

EMBL: Software Developer - Machine Learning

New Scientist - Bioinformatics - Tue, 2019-02-26 04:38
Competitive Salary: EMBL: Software Developer - Machine Learning Location: Cambridge, Cambridgeshire, England
Categories: Job Watch

EMBL: GWAS Catalog Technical Project Lead

New Scientist - Bioinformatics - Tue, 2019-02-26 04:37
Competitive Salary: EMBL: GWAS Catalog Technical Project Lead Location: Cambridge, Cambridgeshire, England
Categories: Job Watch

Hyper Recruitment Solutions (HRS): Information Science Analyst

New Scientist - Bioinformatics - Tue, 2019-02-26 04:36
£17 - £21 per hour, Benefits: 1-2 days working from home: Hyper Recruitment Solutions (HRS): We are currently looking for a Information Science Analyst to join a leading company based in the Slough, Berkshire area. As the Information Science Analyst... Slough
Categories: Job Watch

EMBL: WormBase Project Leader

New Scientist - Bioinformatics - Tue, 2019-02-26 04:35
Competitive Salary: EMBL: WormBase Project Leader Location: Cambridge, Cambridgeshire, England
Categories: Job Watch

EMBL: Content Co-ordinator

New Scientist - Bioinformatics - Tue, 2019-02-26 04:35
Competitive Salary: EMBL: Content Co-ordinator Location: E Cambridge, Cambridgeshire, England
Categories: Job Watch

Genomicist and Bioinformatician—Culture Development - DuPont - Madison, WI

Indeed.com - Bioinformatics - Mon, 2019-02-25 15:57
Education commensurate with a PhD in Computational Biology, Bioinformatics, Genomics, or related discipline preferred or a MS plus five years of experience....
From DuPont - Mon, 25 Feb 2019 20:57:01 GMT - View all Madison, WI jobs
Categories: Job Watch

Neuropathological Assessment of TBI-related Neurodegeneration and Neurocognitive decline - Center Without Walls (NATBI CWOW) (U54 Clinical Trial Not Allowed)

Funding Opportunity RFA-NS-19-030 from the NIH Guide for Grants and Contracts. This FOA invites applications for a multisite study to comprehensively characterize the neuropathological features associated with neurodegeneration and neurocognitive decline in persons with a history of traumatic brain injury (TBI). Investigations should elucidate the contribution of key individual (sex, age at time of injury, time since injury, etc) and injury characteristics (injury severity and frequency) to describe associations between neuropathological burden and antemortem clinicopathologic symptoms, and outline the prevalence of TBI-related parkinsonism, TBI-related Alzheimers, and CTE in the participating brain banks. To further advance research in the area, broad sharing of clinical and neuropathological data will be a critical feature of this FOA including the development of a digital resource for distribution and sharing of assessed neuropathological tissue.

Request for Information (RFI): Institutional Accountability to Promote Inclusive Excellence

Notice NOT-RM-19-001 from the NIH Guide for Grants and Contracts

Clinical and Biological Measures of TBI-related dementia including Chronic Traumatic Encephalopathy (CTE) (R01 Clinical Trial Not Allowed)

Funding Opportunity RFA-NS-19-026 from the NIH Guide for Grants and Contracts. This FOA invites investigation of biological and clinical measures of TBI-related progressive neurodegeneration and neurocognitive decline associated with increased risk for dementia and /or traumatic encephalopathy syndrome (TES) (clinicopathologic diagnostic counterpart to the neuropathological diagnosis of Chronic Traumatic Encephalopathy (CTE)). The overall goal is to advance knowledge of the underlying pathophysiology and clinical characterization of the chronic effects of TBI that distinguish static-chronic TBI cognitive impairment from those that lead to progressive neurodegeneration associated with TES and dementia. Investigations should be conducted in existing, well-characterized populations of patients with a history of TBI, enriched for increased risk of cognitive impairment or dementia, that have been and can continue to be followed longitudinally. A critical feature of this FOA includes the broad sharing of clinical, neuroimaging, physiological, and biospecimen data to further advance research in this area.

Limited Competition: Nonhuman Primate (NHP) Radiation Survivor Cohort (RSC) (U01 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-19-010 from the NIH Guide for Grants and Contracts. The purpose of this limited competition Funding Opportunity Announcement (FOA) is to support continued care for and conduct of specialized research using a unique nonhuman primate (NHP) population. Specifically, the preservation, medical monitoring, study, treatment, and intervention in the development of late effects in NHP survivors of radiation exposure. NHPs most closely resemble human responses to radiation exposure and, as such, long-term studies on a radiation survivor cohort will permit continuous observations and treatment of this valuable population, while providing a critical understanding of the natural history of radiation exposures, including early and late injuries and disease development. The successful applicant must have facilities and staff to care for a combined minimum of 120 irradiated and unirradiated control NHPs, exposed at various ages and available for study, and must be able to accommodate receipt of additional radiation-exposed animals from other government-supported studies.

Pages

Subscribe to Anil Jegga aggregator - Job Watch